The turnover of biotechnology research and experimental development in Italy has experienced significant growth from 2013, with an increase from 242.2 million Euros in 2013 to 806.0 million Euros in 2023. This indicates robust sector growth, exemplified by a 2023 year-on-year increase of 7.88%. The past five years have shown an average annual growth rate (CAGR) of 8.97%. Year-on-year variations highlight the sector's dynamism, with peaks in 2018 (25.39%) and steady growth thereafter. Noteworthy is the decelerating but consistent growth projected up to 2028, with a forecasted CAGR of 4.86%.

Future trends to watch for include:

Ongoing advancements in genomic and personalized medicine.
Increased investment in biopharmaceutical and synthetic biology technologies.
Potential impact of regulatory changes on research funding and collaboration.
Expansion of biotech applications in agriculture and environmental sustainability.